The Risks of Polypharmacy: A Guide for Speech-Language Pathologists with Lisa Miliken episode artwork

EPISODE · Jun 20, 2024 · 1H 4M

The Risks of Polypharmacy: A Guide for Speech-Language Pathologists with Lisa Miliken

from Brainstorms: Functional Neurorehab for SLPs

Guest: Lisa Milliken, MA, CCC-SLP, FNAP, CDP, RAC- CT, CADDCT - In this episode, Renee is joined by Lisa to discuss the impacts of polypharmacy and explore the pathophysiological changes behind drug-induced cognitive impairment, which sheds light on the complexities of this condition. Determining when Post-operative Cognitive Dysfunction (POCD) poses a significant risk is crucial for patient care and recovery, as is understanding how aging changes impact adverse medication reactions. In this episode, join Renee and Lisa as we delve into these topics to enhance our understanding and awareness of cognitive health in medical contexts.Mentioned in this episode:Register for the Aphasia Discourse Conference on June 7

Episode metadata supplied by the publisher feed · Published Jun 20, 2024

Embed this episode

NOW PLAYING

The Risks of Polypharmacy: A Guide for Speech-Language Pathologists with Lisa Miliken

0:00 1:04:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Brainstorms: Functional Neurorehab for SLPs?

This episode is 1 hour and 4 minutes long.

When was this Brainstorms: Functional Neurorehab for SLPs episode published?

This episode was published on June 20, 2024.

Can I download this Brainstorms: Functional Neurorehab for SLPs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!